United Kingdom In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Table Of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
2.2 In Vitro Diagnostics Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 14
3 In Vitro Diagnostics Market, United Kingdom 27
3.1 In Vitro Diagnostics Market, United Kingdom, Revenue ($m), 2007-2021 27
3.2 In Vitro Diagnostics Market, United Kingdom, Revenue Mix ($m), 2014 29
3.3 In Vitro Diagnostics Market, United Kingdom, Category Contribution by Revenue ($m), 2014 30
3.4 In Vitro Diagnostics Market, United Kingdom, Category Comparison by Revenue ($m), 2007-2021 32
3.5 In Vitro Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014 34
3.6 In Vitro Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021 36
3.7 In Vitro Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014 38
4 Clinical Chemistry Market, United Kingdom 40
4.1 Clinical Chemistry Market, United Kingdom, Revenue Mix ($m), 2014 40
4.2 Clinical Chemistry Market, United Kingdom, Segment Contribution (%), 2014 41
4.3 Clinical Chemistry Market, United Kingdom, Revenue ($m), 2007-2014 42
4.4 Clinical Chemistry Market, United Kingdom, Revenue ($m), 2014-2021 44
4.5 Clinical Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 58
4.6 Clinical Chemistry Market, United Kingdom, Company Share by Revenue ($m), 2014 59
5 Genetic Testing Market, United Kingdom 61
5.1 Genetic Testing Market, United Kingdom, Revenue Mix ($m), 2014 61
5.2 Genetic Testing Market, United Kingdom, Segment Contribution (%), 2014 62
5.3 Genetic Testing Market, United Kingdom, Revenue ($m), 2007-2014 63
5.4 Genetic Testing Market, United Kingdom, Revenue ($m), 2014-2021 65
5.5 Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 67
5.6 Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), 2014 68
6 Haematology Market, United Kingdom 70
6.1 Haematology Market, United Kingdom, Revenue Mix ($m), 2014 70
6.2 Haematology Market, United Kingdom, Segment Contribution (%), 2014 71
6.3 Haematology Market, United Kingdom, Revenue ($m), 2007-2014 72
6.4 Haematology Market, United Kingdom, Revenue ($m), 2014-2021 74
6.5 Haematology Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 96
6.6 Haematology Market, United Kingdom, Company Share by Revenue ($m), 2014 97
7 Histology And Cytology Market, United Kingdom 99
7.1 Histology And Cytology Market, United Kingdom, Revenue Mix ($m), 2014 99
7.2 Histology And Cytology Market, United Kingdom, Segment Contribution (%), 2014 100
7.3 Histology And Cytology Market, United Kingdom, Revenue ($m), 2007-2014 101
7.4 Histology And Cytology Market, United Kingdom, Revenue ($m), 2014-2021 103
7.5 Histology and Cytology Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 105
7.6 Histology and Cytology Market, United Kingdom, Company Share by Revenue ($m), 2014 106
8 Immuno Chemistry Market, United Kingdom 108
8.1 Immuno Chemistry Market, United Kingdom, Revenue Mix ($m), 2014 108
8.2 Immuno Chemistry Market, United Kingdom, Segment Contribution (%), 2014 109
8.3 Immuno Chemistry Market, United Kingdom, Revenue ($m), 2007-2014 111
8.4 Immuno Chemistry Market, United Kingdom, Revenue ($m), 2014-2021 113
8.5 Immuno Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 143
8.6 Immuno Chemistry Market, United Kingdom, Company Share by Revenue ($m), 2014 144
9 Infectious Diagnostics Market, United Kingdom 146
9.1 Infectious Diagnostics Market, United Kingdom, Revenue Mix ($m), 2014 146
9.2 Infectious Diagnostics Market, United Kingdom, Segment Contribution (%), 2014 147
9.3 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014 149
9.4 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021 151
9.5 Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 157
9.6 Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014 158
10 Microbiology Culture Market, United Kingdom 160
10.1 Microbiology Culture Market, United Kingdom, Revenue Mix ($m), 2014 160
10.2 Microbiology Culture Market, United Kingdom, Segment Contribution (%), 2014 161
10.3 Microbiology Culture Market, United Kingdom, Revenue ($m), 2007-2014 162
10.4 Microbiology Culture Market, United Kingdom, Revenue ($m), 2014-2021 164
10.5 Microbiology Culture Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 170
10.6 Microbiology Culture Market, United Kingdom, Company Share by Revenue ($m), 2014 171
11 Overview of Key Companies in United Kingdom, In Vitro Diagnostics Market 173
11.1 Siemens Healthcare 173
11.2 F. Hoffmann-La Roche Ltd. 173
11.3 Danaher Corporation 173
11.4 Abbott Laboratories 174
11.5 bioMerieux S.A. 174
11.6 Becton, Dickinson and Company 174
11.7 Sysmex Corporation 175
11.8 Thermo Fisher Scientific Inc. 175
11.9 Bio-Rad Laboratories, Inc. 175
11.10 Alere Inc. 176
11.11 Ortho-Clinical Diagnostics Inc. 176
12 In Vitro Diagnostics Market Pipeline Products 177
13 Financial Deals Landscape 183
13.1 Acquisition 183
13.2 Asset Transactions 189
13.3 Equity Offerings 191
13.4 Partnerships 200
13.5 Private Equity 258
13.6 Venture Financing 259
14 Recent Developments 269
14.1 Corporate Communications 269
14.2 Financial Announcements 300
14.3 Government and Public Interest 374
14.4 Legal And Regulatory 384
14.5 Other Significant Developments 386
14.6 Product News 410
14.7 Research And Development 427
14.8 Strategy And Business Planning 430
15 Appendix 451
15.1 Research Methodology 452
15.2 GlobalData Consulting 453
15.3 Contact Us 453
15.4 Disclaimer 454

List Of Tables
1.1 List of Tables
Table 1: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2007-2021 37
Table 2: In Vitro Diagnostics Market, United Kingdom, Category Contribution by Revenue ($m), 2014 40
Table 3: In Vitro Diagnostics Market, United Kingdom, Category Comparison by Revenue ($m), USD Constant, 2007-2021 42
Table 4: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 44
Table 5: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Table 6: In Vitro Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 48
Table 7: Clinical Chemistry Market, United Kingdom, Segment Contribution (%), 2014 50
Table 8: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 9: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Table 10: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 56
Table 11: Therapeutic Drug Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 58
Table 12: Urine Analysis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 60
Table 13: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 62
Table 14: Therapeutic Drug Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 64
Table 15: Urine Analysis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 66
Table 16: Clinical Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 67
Table 17: Clinical Chemistry Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 69
Table 18: Genetic Testing Market, United Kingdom, Segment Contribution (%), 2014 71
Table 19: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 73
Table 20: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Table 21: Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 76
Table 22: Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 78
Table 23: Haematology Market, United Kingdom, Segment Contribution (%), 2014 80
Table 24: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 25: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 84
Table 26: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 27: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 28: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 90
Table 29: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 92
Table 30: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 94
Table 31: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 32: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 33: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Table 34: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 102
Table 35: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 104
Table 36: Haematology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 105
Table 37: Haematology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 107
Table 38: Histology And Cytology Market, United Kingdom, Segment Contribution (%), 2014 109
Table 39: Histology And Cytology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 111
Table 40: Histology And Cytology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 113
Table 41: Histology and Cytology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 114
Table 42: Histology and Cytology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 116
Table 43: Immuno Chemistry Market, United Kingdom, Segment Contribution (%), 2014 119
Table 44: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 45: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 123
Table 46: Anemia Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 47: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 48: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 49: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 50: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 133
Table 51: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 135
Table 52: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 137
Table 53: Anemia Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 54: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 55: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 56: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 57: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 147
Table 58: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 149
Table 59: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 151
Table 60: Immuno Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 152
Table 61: Immuno Chemistry Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 154
Table 62: Infectious Diagnostics Market, United Kingdom, Segment Contribution (%), 2014 157
Table 63: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 159
Table 64: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 161
Table 65: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 163
Table 66: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 165
Table 67: Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 166
Table 68: Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 168
Table 69: Microbiology Culture Market, United Kingdom, Segment Contribution (%), 2014 170
Table 70: Microbiology Culture Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 172
Table 71: Microbiology Culture Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Table 72: Microbiology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 176
Table 73: Microbiology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 178
Table 74: Microbiology Culture Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 179
Table 75: Microbiology Culture Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 181
Table 76: In Vitro Diagnostics Market Pipeline Products 186
Table 77: ERBA Diagnostics Mannheim Acquires Lumora 192
Table 78: Jin Jing to Acquire EKF Diagnostics 193
Table 79: VWR International Acquires Hichrom 194
Table 80: Norgine Acquires 70% stake in Arc Medical Design 195
Table 81: Abingdon Health Acquires Remaining Stake in Molecular Vision 196
Table 82: Abingdon Health Acquires Serascience for USD3.4 Million 197
Table 83: Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 198
Table 84: EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 199
Table 85: Source BioScience Raises USD6.8 million in Private Placement of Shares 200
Table 86: Oxford Nanopore Raises USD109 Million in Private Placement of Shares 201
Table 87: Avacta Group to Raise up to USD34.2 Million in Private Placement of Shares 202
Table 88: Premaitha Health to Raise USD12.5 Million in Private Placement of Shares 203
Table 89: QuantuMDx Plans IPO 204
Table 90: Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 205
Table 91: Oxford Immunotec Raises USD57.5 Million in Public Offering of Shares 206
Table 92: Quotient to Raise USD27 Million in Private Placement of Shares and Warrants 208
Table 93: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 209
Table 94: Seegene Enters into Co-Development Agreement with BD Life Sciences 210
Table 95: MdxHealth Enters into Licensing Agreement with Erasmus MC 211
Table 96: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 212
Table 97: Sigma-Aldrich Enters into Distribution Agreement with LGC 213
Table 98: OvaGene Oncology Enters into Agreement with Etta Healthcare 214
Table 99: Biodesix Forms Partnership with Biognosys 215
Table 100: InTouch Health Enters into Agreement with iSchemaView 216
Table 101: Cytox Enters into Joint Development Partnership with Affymetrix 217
Table 102: Axiogenesis Enters into Licensing Agreement with GE Healthcare 218
Table 103: Almac Diagnostics Enters into Co-Development Agreement with OncoMed Pharma 219
Table 104: CareDx Enters into Co-Development Agreement with Horizon Discovery 220
Table 105: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 221
Table 106: Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 222
Table 107: AstraZeneca Enters into Research Agreement with Sutter Health 223
Table 108: NetScientific Enters into Joint Venture Agreement with iMPak Health 224
Table 109: Cell Therapy Catapult Enters into Agreement with Asymptote 225
Table 110: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 226
Table 111: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 227
Table 112: Atlas Genetics Enters into Agreement with Pharma Company 228
Table 113: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 229
Table 114: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 230
Table 115: Veracyte Enters into Research Agreement with GE Healthcare 231
Table 116: AngioDynamics Enters into Licensing Agreement with EmboMedics 232
Table 117: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 233
Table 118: Myriad Genetics Expands Agreement with AstraZeneca 234
Table 119: Biocartis Enters into Licensing and Development Agreement with Microbiome 235
Table 120: Esperite Enters into Agreement with Premaitha Health 236
Table 121: CBScientific Enters into Distribution Agreement with UTest 237
Table 122: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 238
Table 123: Population Genetics Enters into Agreement with Case Western Reserve University to Develop Diagnostics Technology 239
Table 124: GE Healthcare Enters into Agreement with Sunnybrook Health Sciences 240
Table 125: GeneThera Enters into Co-Development Agreement with Hudson Robotics 241
Table 126: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 242
Table 127: Ellen Enters into Distribution Agreement with Biosynex 243
Table 128: Angle Enters into Agreement with MD Anderson Cancer Center 244
Table 129: KromaTiD Enters into Distribution Agreement with Tebu-bio 245
Table 130: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 246
Table 131: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 248
Table 132: EKF Diagnostics Enters into Co-Development Agreement with Angle 249
Table 133: BioMerieux Enters into Licensing Agreement with Astute Medical 250
Table 134: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 251
Table 135: Asuragen Enters into Agreement with Cancer Research UK, Cancer Research Technology and Abcodia 252
Table 136: NoemaLife Enters into Distribution Agreement with Horiba Medical 254
Table 137: Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 255
Table 138: NetScientific Enters into Agreement with KU Leuve 256
Table 139: Glyconics Enters into Licensing Agreement with Swansea University 257
Table 140: eBioscience Enters into Distribution Agreement with Binding Site 258
Table 141: Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 259
Table 142: VolitionRx Enters into Co-Development Agreement with University of Oxford 260
Table 143: MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 261
Table 144: Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 262
Table 145: Clinical Genomics Enters into Licensing Agreement with CSIRO 263
Table 146: Affymetrix Enters into Licensing Agreement with Peptide Groove 264
Table 147: TC BioPharm Enters into Co-Development Agreement with Sistemic 265
Table 148: MBio Diagnostics Enters into Co-Development Agreement with the Institute for Global Food Security and Scienion 266
Table 149: Exponent Private Equity to Acquire BBI Diagnostics from Alere for USD164 Million 267
Table 150: Spectromics Raises Funds through Venture Financing Round 268
Table 151: Abcodia Raises USD8.3 Million in Venture Financing 269
Table 152: Atlas Genetics Raises USD20 Million in Series C Financing 271
Table 153: Biofortuna Raises USD2.3 Million in Venture Financing 273
Table 154: DiaCarta Raises USD8 Million in Series A Financing 275
Table 155: 14M Genomics Raises USD19.6 Million in Venture Financing 276
Table 156: Abingdon Health Raises USD3.4 Million in Venture Financing 277

List Of Figures
1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2007-2021 36
Figure 2: In Vitro Diagnostics Market, United Kingdom, Revenue Mix ($m), 2014 38
Figure 3: In Vitro Diagnostics Market, United Kingdom, Category Contribution (%), 2014 39
Figure 4: In Vitro Diagnostics Market, United Kingdom, Category Comparison by Revenue ($m), USD Constant, 2007-2021 41
Figure 5: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 43
Figure 6: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Figure 7: In Vitro Diagnostics Market, United Kingdom, Company Share (%) 2014 47
Figure 8: Clinical Chemistry Market, United Kingdom, Revenue Mix ($m), 2014 49
Figure 9: Clinical Chemistry Market, United Kingdom, Segment Contribution (%), 2014 50
Figure 10: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 11: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Figure 12: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 55
Figure 13: Therapeutic Drug Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 57
Figure 14: Urine Analysis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 59
Figure 15: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 61
Figure 16: Therapeutic Drug Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 63
Figure 17: Urine Analysis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 65
Figure 18: Clinical Chemistry Market, United Kingdom, Company Share (%) 2014 68
Figure 19: Genetic Testing Market, United Kingdom, Revenue Mix ($m), 2014 70
Figure 20: Genetic Testing Market, United Kingdom, Segment Contribution (%), 2014 71
Figure 21: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 72
Figure 22: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Figure 23: Genetic Testing Market, United Kingdom, Company Share (%) 2014 77
Figure 24: Haematology Market, United Kingdom, Revenue Mix ($m), 2014 79
Figure 25: Haematology Market, United Kingdom, Segment Contribution (%), 2014 80
Figure 26: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 27: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 83
Figure 28: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 29: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 30: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 89
Figure 31: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 91
Figure 32: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 93
Figure 33: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 34: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 35: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Figure 36: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Figure 37: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 103
Figure 38: Haematology Market, United Kingdom, Company Share (%) 2014 106
Figure 39: Histology And Cytology Market, United Kingdom, Revenue Mix ($m), 2014 108
Figure 40: Histology And Cytology Market, United Kingdom, Segment Contribution (%), 2014 109
Figure 41: Histology And Cytology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 110
Figure 42: Histology And Cytology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 112
Figure 43: Histology and Cytology Market, United Kingdom, Company Share (%) 2014 115
Figure 44: Immuno Chemistry Market, United Kingdom, Revenue Mix ($m), 2014 117
Figure 45: Immuno Chemistry Market, United Kingdom, Segment Contribution (%), 2014 118
Figure 46: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 47: Immuno Chemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 122
Figure 48: Anemia Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 49: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 50: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 51: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 52: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 132
Figure 53: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 134
Figure 54: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 136
Figure 55: Anemia Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 56: Disease Specific Immunochemistry Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 57: Endocrinology Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 58: IgE Allergy Blood Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Figure 59: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Figure 60: Immunochemistry Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 148
Figure 61: Vitamins Tests Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 150
Figure 62: Immuno Chemistry Market, United Kingdom, Company Share (%) 2014 153
Figure 63: Infectious Diagnostics Market, United Kingdom, Revenue Mix ($m), 2014 155
Figure 64: Infectious Diagnostics Market, United Kingdom, Segment Contribution (%), 2014 156
Figure 65: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 158
Figure 66: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Figure 67: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 162
Figure 68: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 164
Figure 69: Infectious Diagnostics Market, United Kingdom, Company Share (%) 2014 167
Figure 70: Microbiology Culture Market, United Kingdom, Revenue Mix ($m), 2014 169
Figure 71: Microbiology Culture Market, United Kingdom, Segment Contribution (%), 2014 170
Figure 72: Microbiology Culture Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 171
Figure 73: Microbiology Culture Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 173
Figure 74: Microbiology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 175
Figure 75: Microbiology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 177
Figure 76: Microbiology Culture Market, United Kingdom, Company Share (%) 2014 180

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.